Bibliography
Traber, K. E., Okamoto, H., Kurono, C., Baba, M., Saliou, C., Soji, T., Packer, L., & Okamoto, T. (1999). Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-α-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells. International Immunology, 11(2), 143â150.
References
37
Referenced
34
-
Baeuerle, P. A. and Baichwal, V. R. 1997. NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv. Immunol.65:111.
(
10.1016/S0065-2776(08)60742-7
) -
Baldwin, A. S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol.14:649.
(
10.1146/annurev.immunol.14.1.649
) -
Thanos, D. and Maniatis, T. 1995. NF-κB: a lesson in family values. Cell80:529.
(
10.1016/0092-8674(95)90506-5
) -
Okamoto, T., Sakurada, S., Yang, J.-P. and Merin, J. P. 1997. Regulation of NF-κB and disease control: identification of a novel serine kinase and thioredoxin as effectors for signal transduction pathway for NF-κB activation. Curr. Topics Cell. Reg.35:149.
(
10.1016/S0070-2137(97)80006-4
) -
Hayashi, T., Ueno, Y. and Okamoto, T. 1993. Oxidoreductive regulation of nuclear factor kappa B. J. Biol. Chem.268:11380.
(
10.1016/S0021-9258(18)82135-4
) -
Okamoto, T., Josephs, S. F., Sadaie, M. R. and Wong-Staal, F. 1990. Transcriptional activation from the long-terminal repeat of human immunodeficiency virus in vitro. Virology177:606.
(
10.1016/0042-6822(90)90526-W
) -
Baeuerle, P. A. and Baltimore, D. 1988. I-kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science242:540.
(
10.1126/science.3140380
) -
Ghosh, S. and Baltimore, D. 1990. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I-kappa B. Nature344:678.
(
10.1038/344678a0
) -
Arya, S. R., Guo, C., Josephs, S. F. and Wong-Staal, F. 1985. Trans-activator gene of human lymphotropic virus type III (HTLVIII). Science229:74.
(
10.1126/science.2990040
) -
Okamoto, T. and Wong-Staal, F. 1986. Demonstration of virus-specific transcriptional activator(s) in cells infected with HTLV-III by an in vitro cell-free system. Cell47:29.
(
10.1016/0092-8674(86)90363-6
) -
Okamoto, T., Matsuyama, T., Mori, S., Manamoto, Y., Kobayashi, N., Yamamoto, N., Josephs, S. F., Wong-Staal, F. and Shimotohno, K. 1989. Augmentation of human immunodeficiency virus type 1 gene expression by tumor necrosis factor alpha. AIDS Res. Hum Retroviruses5:131.
(
10.1089/aid.1989.5.131
) -
Bohnlein, E., Lowenthal, J. W., Siekevitz, M., Ballard, D. W., Franza, B. R. and Greene, W. C. 1988. The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV. Cell53:827.
(
10.1016/0092-8674(88)90099-2
) - Madhok, R., Crilly, A., Murphy, E., Smith, J., Watson, J. and Capell, H. A, 1993. Gold therapy lowers serum interleukin levels in rheumatoid arthritis. J. Rheumatol.20:630.
-
Crilly, A., Madhok, R., Watson, J., Capell, H. A. and Sturrock, R. D. 1994. Production of interleukin-6 by monocytes isolated from rheumatoid arthritis patients receiving second-line drug therapy. Br. J. Rheumatol.33:821.
(
10.1093/rheumatology/33.9.821
) -
Yanni, G., Nabil, M., Farahat, M. R., Poston, R. N. and Panayi, G. S. 1994. Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane. Ann. Rheum. Dis.53:315.
(
10.1136/ard.53.5.315
) -
Loetscher, P., Dewald, B., Baggiolini, M. and Seitz, M. 1994. Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes. Effects of anti-rheumatic drugs. Cytokine6:162.
(
10.1016/1043-4666(94)90038-8
) -
Seitz, M, Dewald, B., Ceska, M., Gerber, N. and Baggiolini, M. 1992. Interleukin-8 in inflammatory rheumatic diseases: synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate. Rheumatol. Int.12:159.
(
10.1007/BF00274936
) -
Yoshida, S., Kato, T., Sakurada, S., Kurono, C., Yang, J.-P., Matsui, N., Soji, T. and Okamoto, T. 1999. Inhibition of IL-6 and IL-8 induction from primary rheumatoid synovial fibroblasts by treatment with aurothioglucose. Int. Immunol.11:151.
(
10.1093/intimm/11.2.151
) -
Williams, D. H., Jeffery, L. J. and Murray, E. J. 1992. Aurothioglucose inhibits induced NF-κB and AP-1 activity by acting as an IL-1 functional antagonist. Biochim. Biophys. Acta1180:9.
(
10.1016/0925-4439(92)90020-N
) -
Yang, J.-P., Merin, J. P., Nakano, T., Kato, T., Kitade, S. and Okamoto, T. 1995. Inhibition of the DNA-binding activity of NF-κB by gold compounds in vitro. FEBS Lett.361:89.
(
10.1016/0014-5793(95)00157-5
) -
Butera, S. T., Rerez, V. L., Wu, B.-Y., Nabel, G. J. and Folks, T. M. 1991. Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of activation in a CD4+ cell model of chronic infection. J. Virol.65:4645.
(
10.1128/JVI.65.9.4645-4653.1991
) -
Folks, T. M., Clouse, K. A., Justement, J., Rabson, A., Duh, E., Kehrl, J. H. and Fauci, A. S. 1986. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl Acad. Sci. USA86:2365.
(
10.1073/pnas.86.7.2365
) -
Luo, Y., Madore, S. J., Parslow, T. G., Cullen, B. R. and Peterlin, B. M. 1993. Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus 1 in cells. J. Virol.67:5617.
(
10.1128/JVI.67.9.5617-5622.1993
) -
Okamoto, T., Ogiwara, H., Hayashi, T., Mitsui, A., Kawabe, T. and Yodoi, J. 1992. Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism. Int. Immunol.4:811.
(
10.1093/intimm/4.7.811
) -
Vandeputte, C., Guizon, I., Genestie-Denis, I., Vannier, B. and Lorenzon, G. 1994. A microtiter plate assay for total glutathione and glutathione disulfide contents in cultures/isolated cells: performance study of a new miniaturized protocol. Cell Biol. Toxicol.10:415.
(
10.1007/BF00755791
) -
Gallagher, E., Kavanagh, T. and Eaton, D. 1994. Glutathione, oxidized glutathione and mixed disulfides in biological samples. Methods Toxicol.1B:349.
(
10.1016/B978-0-08-092440-3.50035-X
) - Okamoto, K. and Utamura, M. 1938. Biologische untersuchungen des Goldes. 1 Mitteilung uber die histochemische Gold nachweis-methode. Acta Scholae. Med. Kioto.22:373.
-
Luft, J. 1961. Improvement in epoxy resin embedding methods. J. Biophys. Biochem. Cytol.9:409.
(
10.1083/jcb.9.2.409
) -
Mascarenhas, B., Granda, J. and Freyberg, R. 1972. Gold metabolism in patients with rheumatoid arthritis treated with gold compounds—reinvestigated. Arthritis Rheum.15:391.
(
10.1002/art.1780150410
) -
Merin, J. P., Matsuyama, M., Kira, T., Baba, M. and Okamoto, T. 1996. Alpha-lipoic acid blocks HIV-1 LTR-dependent expression of hygromycin resistance in THP-1 stable transformants. FEBS Lett.394:9.
(
10.1016/0014-5793(96)00919-2
) - Shapiro, D. L. and Masci, J. R. 1996. Treatment of HIV associated psoriatic arthritis with oral gold. J. Rheumatol.23:1818.
-
Jacque, J. M., Fernandez, B., Arenzana-Seisdedos, F., Thomas, D,. Baleux, F., Virelizier, J. L. and Bachelerie, F. 1996. Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kB is needed for persistent viral replication in monocytes. J. Virol.70:2930.
(
10.1128/JVI.70.5.2930-2938.1996
) -
Sato, T., Asamitsu, K., Yang, J.-P., Takahashi, N., Tetsuka, T., Yoneyama, A., Kanagawa, A. and Okamoto, T. 1998. Inhibition of HIV-1 replication by fasudil hydrochloride. AIDS Res. Hum. Retroviruses14:293.
(
10.1089/aid.1998.14.293
) -
Vint, I. A., Foreman, J. C. and Chain, B. M. 1994. The gold anti-rheumatic drug auranofin governs T cell activation by enhancing oxygen free radical production. Eur. J. Immunol.24:1961.
(
10.1002/eji.1830240904
) - Tozawa, K., Sakurada, S., Kohri, K. and Okamoto, T. 1995. Effects of anti-nuclear factor κB reagents in blocking adhesion of human cancer cells to vascular endothelial cells. Cancer Res.55:4162.
-
Sakurada, S., Kato, T. and Okamoto,T. 1996. Induction of cytokines and ICAM-1 by proinflammatory cytokines in primary rheumatoid synovial fibroblasts and inhibition by N-acetyl-l-cysteine and aspirin. Int. Immunol.8:1483.
(
10.1093/intimm/8.10.1483
) - Zabel, U., Schreck, R. and Baeuerle, P. A. 1991. DNA binding of purified transcription factor NF-kappa B: Affinity, specificity, Zn2+ dependence, and differential half-site recognition. J. Biol. Chem.266:252.
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 6:22 p.m.) |
Deposited | 4 years, 3 months ago (May 17, 2021, 11:54 a.m.) |
Indexed | 2 weeks ago (Aug. 23, 2025, 12:59 a.m.) |
Issued | 26 years, 7 months ago (Feb. 1, 1999) |
Published | 26 years, 7 months ago (Feb. 1, 1999) |
Published Online | 26 years, 7 months ago (Feb. 1, 1999) |
Published Print | 26 years, 7 months ago (Feb. 1, 1999) |
@article{Traber_1999, title={Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-α-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells}, volume={11}, ISSN={0953-8178}, url={http://dx.doi.org/10.1093/intimm/11.2.143}, DOI={10.1093/intimm/11.2.143}, number={2}, journal={International Immunology}, publisher={Oxford University Press (OUP)}, author={Traber, Katrina E. and Okamoto, Hiroshi and Kurono, Chieko and Baba, Masanori and Saliou, Claude and Soji, Tsuyoshi and Packer, Lester and Okamoto, Takashi}, year={1999}, month=feb, pages={143–150} }